NovaBay Pharmaceuticals Statistics
Total Valuation
NBY has a market cap or net worth of $3.52 million. The enterprise value is -$3.82 million.
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025, after market close.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
NBY has 5.82 million shares outstanding. The number of shares has increased by 3,384.14% in one year.
| Current Share Class | 5.82M |
| Shares Outstanding | 5.82M |
| Shares Change (YoY) | +3,384.14% |
| Shares Change (QoQ) | -32.27% |
| Owned by Insiders (%) | 0.01% |
| Owned by Institutions (%) | 6.24% |
| Float | 4.80M |
Valuation Ratios
The trailing PE ratio is 1.33.
| PE Ratio | 1.33 |
| Forward PE | n/a |
| PS Ratio | 0.29 |
| Forward PS | 0.28 |
| PB Ratio | 0.58 |
| P/TBV Ratio | 0.57 |
| P/FCF Ratio | 0.70 |
| P/OCF Ratio | 0.70 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.95, with a Debt / Equity ratio of 0.18.
| Current Ratio | 2.95 |
| Quick Ratio | 2.86 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | 0.22 |
| Interest Coverage | -11.43 |
Financial Efficiency
Return on equity (ROE) is -240.71% and return on invested capital (ROIC) is -68.15%.
| Return on Equity (ROE) | -240.71% |
| Return on Assets (ROA) | -44.19% |
| Return on Invested Capital (ROIC) | -68.15% |
| Return on Capital Employed (ROCE) | -79.12% |
| Revenue Per Employee | $698,643 |
| Profits Per Employee | $189,714 |
| Employee Count | 14 |
| Asset Turnover | 1.28 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -71.95% in the last 52 weeks. The beta is 0.41, so NBY's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -71.95% |
| 50-Day Moving Average | 0.58 |
| 200-Day Moving Average | 0.62 |
| Relative Strength Index (RSI) | 55.29 |
| Average Volume (20 Days) | 32,081 |
Short Selling Information
The latest short interest is 39,704, so 0.68% of the outstanding shares have been sold short.
| Short Interest | 39,704 |
| Short Previous Month | 42,786 |
| Short % of Shares Out | 0.68% |
| Short % of Float | 0.83% |
| Short Ratio (days to cover) | 1.16 |
Income Statement
In the last 12 months, NBY had revenue of $9.78 million and earned $2.66 million in profits. Earnings per share was $0.57.
| Revenue | 9.78M |
| Gross Profit | 6.48M |
| Operating Income | -5.38M |
| Pretax Income | -11.12M |
| Net Income | 2.66M |
| EBITDA | -5.35M |
| EBIT | -5.38M |
| Earnings Per Share (EPS) | $0.57 |
Full Income StatementBalance Sheet
The company has $8.47 million in cash and $1.13 million in debt, giving a net cash position of $7.34 million or $1.26 per share.
| Cash & Cash Equivalents | 8.47M |
| Total Debt | 1.13M |
| Net Cash | 7.34M |
| Net Cash Per Share | $1.26 |
| Equity (Book Value) | 6.17M |
| Book Value Per Share | 1.06 |
| Working Capital | 5.97M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $5.06 million and capital expenditures -$4,000, giving a free cash flow of $5.06 million.
| Operating Cash Flow | 5.06M |
| Capital Expenditures | -4,000 |
| Free Cash Flow | 5.06M |
| FCF Per Share | $0.87 |
Full Cash Flow StatementMargins
Gross margin is 66.26%, with operating and profit margins of -55.05% and 37.43%.
| Gross Margin | 66.26% |
| Operating Margin | -55.05% |
| Pretax Margin | -77.86% |
| Profit Margin | 37.43% |
| EBITDA Margin | -54.74% |
| EBIT Margin | -55.05% |
| FCF Margin | 51.73% |
Dividends & Yields
NBY does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -3,384.14% |
| Shareholder Yield | -3,384.14% |
| Earnings Yield | 75.38% |
| FCF Yield | 143.61% |
Analyst Forecast
The average price target for NBY is $0.85, which is 40.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $0.85 |
| Price Target Difference | 40.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on May 31, 2024. It was a reverse split with a ratio of 0.028571429:1.
| Last Split Date | May 31, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.028571429:1 |
Scores
NBY has an Altman Z-Score of -24.52 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -24.52 |
| Piotroski F-Score | 6 |
